That’s a fact. A new condom capable of “killing” sexually transmitted diseases like HIV has been approved by Australian regulators and could be available within months. Australian biotech firm Starpharma has developed an antiviral compound called VivaGel, according to Australia’s ABC News. VivaGel’s antiviral compound, when used as a condom lubricant, can reduce the risk of exposure to viruses that cause sexually transmitted diseases. In the lab, the lubricant’s antimicrobial agent astodrimer sodium inactivated up to 99.9 percent of HIV human immunodeficiency virus (HIV), herpes simplex virus (HSV), and human papillomavirus (HPV).

In July, Starpharma received regulatory approval from Australia’s Therapeutic Goods Administration (TGA), which performs in a similar way to the U.S. Food and Drug Administration (FDA). The conformity assessment certification means the product will soon be available to consumers. While condoms are considered the best protection against sexually transmitted diseases, Dr. Jackie Fairley, Starpharma’s chief executive officer said that they are not foolproof

Click Here To Read More